Latest News about ABMD
Recent news which mentions ABMD
   Is Johnson & Johnson an Underrated Growth Stock?
   
  
  
  November 02, 2022
  From Motley Fool
 From Benzinga
 
   Gartner, Sony, Uber And Other Big Gainers From Tuesday
   
  
  
  November 02, 2022
  From Benzinga
 
   Why Abiomed Stock Skyrocketed Today
   
  
  
  November 01, 2022
  From Motley Fool
 
   What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
   
  
  
  November 01, 2022
  From Benzinga
 
   10 Best Stocks to Buy Now in November
   
  
  
  November 01, 2022
  From Motley Fool
 
   Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
   
  
  
  November 01, 2022
  From Benzinga
 
   Poseidon’s $10.9 billion take-private deal for Atlas Corp. sets sail at sweetened price
   
  
  
  November 01, 2022
  From MarketWatch
 
   12 Health Care Stocks Moving In Tuesday's Intraday Session
   
  
  
  November 01, 2022
  From Benzinga
 
   Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  November 01, 2022
  From Benzinga
 
   Dow Drops Over 200 Points; Crude Oil Rises Sharply
   
  
  
  November 01, 2022
  From Benzinga
 
   Why Is Uber Stock Up Today?
   
  
  
  November 01, 2022
  From InvestorPlace
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
   
  
  
  November 01, 2022
  From Benzinga
 
   US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views
   
  
  
  November 01, 2022
  From Benzinga
 
   Why Is Carvana (CVNA) Stock Up 15% Today?
   
  
  
  November 01, 2022
  From InvestorPlace
 
   Why Is Abiomed (ABMD) Stock Up 50% Today?
   
  
  
  November 01, 2022
  From InvestorPlace
 
   Johnson & Johnson Expands Cardiovascular Portfolio, Bets $16B In Abiomed's Heart Failure Devices
   
  
  
  November 01, 2022
  From Benzinga
 
   Uber Rides Higher, but Here's Tuesday's Big Stock Winner
   
  
  
  November 01, 2022
  From Motley Fool
 From InvestorPlace
 
   This reliable indicator of recession has yet to buckle, and so the Fed won’t either, strategist says
   
  
  
  November 01, 2022
  From MarketWatch
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
   
  
  
  October 13, 2022
  From Benzinga
 
   20 value stocks whose growth potential is overlooked by investors
   
  
  
  September 12, 2022
  From MarketWatch
 
   Abiomed's Impella Shows Heart Function, Symptom Improvements For High-Risk PCI Patients
   
  August 16, 2022
  Tickers 
   ABMD
  
  
  From Benzinga
 
   Quant Ratings Updated on 97 Stocks
   
  
  
  June 28, 2022
  From InvestorPlace
 
   Quant Ratings Updated on 85 Stocks
   
  
  
  May 31, 2022
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
